Verrica Pharmaceuticals Aktie
WKN DE: A2JPEV / ISIN: US92511W1080
|
19.09.2025 18:19:09
|
Verrica Pharmaceuticals Stock Jumps 17% On Japan Approval Of YCANTH
(RTTNews) - Verrica Pharmaceuticals Inc. (VRCA) rose 16.58 percent to $4.71 on Friday, gaining $0.67, after its partner Torii Pharmaceutical received Japanese Ministry of Health, Labour and Welfare approval for YCANTH to treat Molluscum Contagiosum. The stock opened at $4.48 and traded between $4.35 and $4.90, compared with a previous close of $4.04 on the Nasdaq. Trading volume reached 7.34 million shares, far above the average of 0.06 million. Verrica trades within a 52-week range of $3.82 to $19.50.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Verrica Pharmaceuticals Inc Registered Shsmehr Nachrichten
| Keine Nachrichten verfügbar. |